ten years a policy of tighter control of diabetes has been in general adopted, and fetal macrosomia has declined. However, both the mean birth weight and the percentage of oversized babies are still high, much higher than normal, in all case studies reported so far. In a recent clinical study with a small number of cases [18] , the pregnant diabetics with strictly regulated blood sugar levels gave birth to growth retarded infants. The authors explained this as follows: in pregnant diabetics, for some still unknown cause, fetal development is inhibited in the early weeks of gestation. Later in pregnancy, exaggerated activity of the glucoseinsulin system more than compensates for the delayed initial growth, bringing about fetal macrosomia. When there is strict metabolic con-trol of the maternal illness, the late macrosomic stimulus is removed and the negative effect of the delayed initial growth is allowed to manifest itself, causing the fetus to be growth retarded [18] .
The aim of our study was to see whether or not strict metabolic control of the diabetic mother really does prevent fetal macrosomia and, if so, whether this prevention results in normal or in retarded fetal growth.
Material and methods
The birth weights of infants of the Milan series of pregnant diabetics [14, 15] have been analyzed. Both pregnant women with gestational diabetes (White's Class A) and those with clinical diabetes (Classes B -F) had been treated with the maximal tolerated dose (MTD) of insulin. A detailed description of this therapeutic regimen and the perinatal results have already been published [14, 15] .
The population consisted of 484 infants with 53 cases excluded because there were factors in addition to maternal diabetes that may have influenced fetal development (toxemia, congenital malformations, etc.). The remaining 431 infants were distributed into groups according to the severity of maternal diabetes: 217, gestational diabetes (Class A); 123, clinical diabetes without vascular complications (Classes B and C); 91, clinical diabetes with vascular complications (Classes D, E and F). Infants of Class E were also considered separately. They were born to mothers with gestational or clinical diabetes and vascular pathology affecting only the pelvic vessels.
Comparison with the birth weights of control newborns
The control group consisted of newborns whose weights are generally assumed to be representative of our region (Northern Italy) [5] . This series was matched for sex and gestational age to each of the diabetic groups with which it was being compared. The averages (table I) and the centile distributions (figure 1) of the birth weights were compared. The data were analyzed with the Student t-test and the Kolmogorov-Smirnov test. Data for centile distributions are plotted on probability paper (figure 1).
Comparison with the birth weights of infants born in previous pregnancies to the multiparae in the case study
The multiparae (para II, 60; para III, 21) included in the analyses met the following criteria: -delivery time in the present pregnancy 5= 36th week; -in the present pregnancy, maternal diabetes controlled with MTD insulin within the 30th week; -delivery during the last month of gestation in previous pregnancies; -no treatment with MTD insulin in the previous pregnancies; -previous pregnancies and delivery not followed in our Center.
The mean birth weights in the last pregnancy were compared with the mean birth weights in the previous pregnancies, namely the first in para II and the second in para III (t-test for paired data) (table II) . The pairs of siblings of the two pregnancies were also compared and figure 3 ). Since the patients were not treated with MTD insulin in either of the two pregnancies, we expected to find no differences between the birth weights of these infants.
Results

Comparison with the birth weights of control newborns
As shown in table I, the mean birth weight of the infants of Class A was 46 g less than that for the controls, while the mean birth weight of infants of Classes B and C was 46 g more, neither difference being statistically significant. The mean birth weight of infants of Classes D, E and F was 177 g less than in the control More detailed information is obtained from the comparison of the centiles of the infants' weights ( figure 1 ). There was a small difference between the centiles of weights of all the infants studied and those of the controls. The two plots of centile distributions are close, but the difference is significant (p < 0.01). The weight differences fluctuate around 70 g (2%) along the plots. When comparing Class A and Classes B and C with the controls, the differences between the lines of centiles are slight (Class A) (p < 0.01) or almost non-existent (Classes B and C) (p > 0.05). When Class A is compared with the controls, the difference in weight in- creases from 7 g (0.3%) to 87 (2%), going from centiles 12.5 to 87.5. The weight difference between Classes B and C and controls is only a few grams, reaching a maximum of 1%. There is marked difference between the centiles of weight for infants in Classes D, E and F and those in the control group. In fact, the two plots of centile distribution are well separated (p < 0.01) and the weights of Classes D, E and F are much lower all along the line. The difference increases from the higher to the lower centiles and remains around 220 -250 g below the 50th centile. There is a great difference between Class E and the controls (p < 0.05).
Comparison with the birth weights of the infants born in previous pregnancies to multiparae in the case study
Any differences there were between the birth weights in the present and the previous pregnancy may have been due not only to the strict control of maternal diabetes in the present pregnancy, but also to differences between the groups in sex and gestational age of the fetus and maternal parity. However, the groups of infants compared were homogeneous in terms of sex distribution. Differences of sex between one sibling and another, e. g. 1st male sibling and 2nd female sibling, were counterbalanced by differences of sex in the opposite direction, i. e. 1st female and 2nd male. The other two variables should have had positive effects, i. e. favoring a higher birth weight of the infant of the present pregnancy. In fact, we waited for spontaneous labor (mean gestational age 39 week in every Class, table II), while delivery had probably been induced in the preceding pregnancy, which is common practice in diabetics, except for those of Class A. As regards the influence of parity, the birth weight tends to increase in subsequent pregnancies after the first, and the present pregnancy of our multiparae was, obviously, the latest one. Accordingly, a lower birthweight of the last infant than of the preceding would not only be attributable to the strict control of maternal diabetes, but even more significant.
In the para II of every Class, the mean birth weight fell from the 1st to the 2nd pregnancy (table II) . The mean birth weights of the first infants in Class A (3835 g) and Classes B and C (4033 g) were higher than expected at 40 weeks', whereas, the mean birth weights in the second (3215 g and 3337 g) resembled those of normal newborns at 38 -39 weeks. In diabetics with vascular complications (Classes D, E and F), the mean birth weight of the first infants was similar to that of normal newborns, but the mean birth weight of the second (2865 g) was lower than expected at 38 -39 weeks.
For the para III of Class A and Classes B and C (table II) , the mean birth weights were higher than expected in the first infants (3520 g and 3886 g) and still high in the second pregnancy (mothers not controlled with MTD insulin). The weight reduction in the third infants (mothers now compensated during pregnancy with MTD insulin) was similar to that observed in the para II.
As shown in figures 2 and 3 (B and C), the weight reduction in infants whose mothers were treated with the MTD insulin is directly proportional to the birth weight of the preceding sibling. The correlation is statistically significant for every comparison. On the contrary, no correlation could be observed when maternal diabetes was not strictly controlled. In fact, in the second pregnancy of para III the tendency toward overweight infants observed in the preceding pregnancy was confirmed and even worsened ( figure 3, A) . From the graphs we can observe that there is an end-point for weight reduction in the latest sibling (maternal diabetes strictly compensated), represented by the intercept of the regression line on the horizontal line. In fact, at this point the regression line, running from right to left, enters the quadrant in which the weight difference has a positive sign, i. e. the weight of the latest sibling, instead of being less, increases. At this intercept, in pregnant diabetics without vascular complications the birth weights were similar to those of control newborns of the same gestational age (para II: Class A 3136 g, B and C 3117 g; para III: Class A 3195 g, B and C 3110 g). On the contrary, in the para II with vascular complications the end-point for the weight reduction of the latest sibling is a weight (2742 g) which is lower than that of control newborns.
Comment
The results of this study clearly demonstrate that fetal macrosomia can be prevented in pregnant diabetic women. In fact, except for infants of pregnant diabetics with vascular complications, there was no significant difference between the averages and the centile distributions of weights of controls and infants of diabetics mothers (table I, figure 1 ). Our results do not indicate that there is any risk of fetal growth retardation as a consequence of the compensation of maternal diabetes itself [18] . It must be emphasized that our pregnant diabetics were those most likely to give birth to growthretarded infants, since the dose of insulin they received in pregnancy was the maximum tolerated. It is particularly noticeable for the multiparae that for the birth weight decrease in the latest infants, as compared with the birth weights of the preceding siblings (figures 2 and 3), there is a weight-limit under which the weight decrease due to maternal metabolic compensation does not go, this limit corresponds to the normal birth weight for infants of mothers without vascular complications.
As shown by the high incidence of fetal macrosomia in patients with gestational diabetes, even a minimal disturbance of fuel metabolism in the mother is sufficient to cause an excess of substrate to the fetus demonstrating, that normal fetal growth requires excellent control of diabetes in pregnancy. In our case study this was secured throughout pregnancy by administration of the MTD of insulin. In fact, maternal blood glucose was normalized, even though this is not the specific purpose of this therapeutic regimen [16] . It is noticeable that in multiparae (table II) the birth weights of the infants in the latest pregnancy were drastically smaller than the birth weights of the infants in their previous pregnancies (no MTD insulin). Moreover, the reduction was greater, the greater the birth weight of the corresponding sibling in the previous pregnancy (figures 2 and 3). This suggests that the control of the weight increase that can be obtained by compensation of maternal diabetes is proportional to the risk of fetal macrosomia.
All the studies published have shown that the high incidence of large babies in gestational diabetic women is not significantly decreased when these patients are treated only by diet. Even though their metabolic abnormality is slight, its correction requires insulin therapy, and we report here for the first time the normalization of the birth weight of the infants of gestational diabetic mothers (table I, figure 1 ). Substitution of a clinical index for blood glucose in the regulation of insulin dosage makes the scheme of insulin administration at the MTD particularly suitable for the treatment of these patients. In our population the only tendency to undersized babies was seen in diabetic pregnancies with vascular complications (table I, figure 1 ). This could have been anticipated since placental blood flow, on which the access of substrates to the fetus depends, is greatly impaired in these patients. In this study, we saw that even vascular damage limited to the pelvic vessels (Class E) could greatly retard fetal growth (table I, figure 1 ). This risk has not been remarked upon in the literature, because pelvic vascular pathology is usually disregarded and the patients remain undifferentiated among pregnant diabetics of Classes A -C. Their frequency seems to be high. If, in the present study, we eliminate those infants in Classes A-C whose mothers did not have pelvic vessel examinations and redistribute Class E infants into these Classes, the incidence of these infants in Class A was 17% and in Classes B and C 12%.
It has been shown that in pregnant diabetics there is no correlation between infant birth weight and maternal blood glucose level [9, 11] and, in addition, that infants of diabetic mothers, even though oversized for gestational age, are not as large as they should be according to their hyperinsulinism [13] . This would imply that fetal macrosomia cannot be due only to maternal hyperglycemia and fetal hyperinsulinism and that it could not be prevented only by strict control of maternal diabetes. We believe that the lack of correlation might be explained by the results of recent animal studies [3] . It has been shown that direct fetal insulin infusion is accompanied by an increase in umbilical glucose uptake, a decrease in fetal plasma glucose concentration and a progressive decline in fetal blood oxygen content. Up to now, the data obtained in these studies has been used to explain sudden fetal death in diabetics during the last month of pregnancy [1, 3] . Nevertheless, it seems reasonable to believe that these episodes of fetal hypoxia could vary in degree and duration and not always result in fetal death. During these episodes, the fetus needs a marked increase in the glycolysis rate, since the amount of energy released during the conversion of glucose to lactic acid is only a fraction of that released in its complete oxidation to carbon dioxide and water [17] . Accordingly, the hypoxic fetus would have to metabolize much more glucose to produce the same amount of energy and the burning of some of the excess glucose transferred to the fetus from the diabetic mother could slow down fetal overgrowth. As a result, in non-controlled diabetic pregnancy the birth weight would not correlate with the maternal blood sugar level and, even though it is high for gestational age, it will always be lower than expected from the degree of fetal hyperinsulinism.
There are many indirect proofs of fetal hypoxia in diabetic pregnancy [10, 19, 20] . However, direct evidence has been obtained only by BERGLUND and ZETTERSTRÖM [2] , who have found the oxygen content in the umbilical cord to be below normal limits in infants of diabetics born by cesarean section. If future studies confirm that fetal hyperinsulinism causes hypoxia as it does in experimental animals, this would be a further reason for strictly controlling maternal diabetes and all aspects of fetal overgrowth, including those which seem at present to be inconsistent with the hyperglycemia-hyperinsulinism theory, will be explained without invoking any mechanism beyond that encompassed by the theory itself.
Summary
In this study the birth weights of 431 infants of diabetic mothers of the Milan series [14, 15] have been compared with the birth weights of infants of a control group [5] . The averages and the centile distributions of weights of infants of gestational diabetic mothers (Class A) and of diabetic mothers without vascular complications (Classes B and C) did not differ substantially from those of control newborns (table I, figure 1 ). This confirms the clinical indication, based on the hyperglycemia-hyperinsulinism theory [12] that fetal macrosomia can be prevented provided maternal metabolism is strictly controlled. In this series insulin was administered at the maximal tolerated dose (MTD), a therapeutic regimen that provides excellent metabolic control of the mother [14, 15, 16] . In multiparae, the birth weights of the infants of the latest pregnancy were drastically lower than the birth weights of the infants in their previous pregnancies (without MTD insulin) (table II) . Our results do not confirm the recent hypothesis [18] that pregnant diabetics with strict metabolic control during pregnancy generally give birth to growth retarded infants. The MTD of insulin has also been administered to gestational diabetic mothers, and fetal macrosomia was prevented (table I, figure 1 ). This confirms the opinion of those who believe that a diet-regimen must be accompanied by insulin administration to correct the slight metabolic abnormality of these patients. As would be expected because of placental insufficiency, infants of patients with vascular complications, including those who have only calcifications of the pelvic vessels (White' Class E), were growth retarded (table I, figure 1 ). The risk of fetal growth retardation in Class E has not been remarked upon in the literature, since pathology of pelvic vessels is usually disregarded and the patients remain undifferentiated among Classes A -C. The possibility to prevent fetal macrosomia with a strict control of maternal diabetes has been questioned because of the lack of correlation between fetal macrosomia and the degree of maternal hyperglycemia [9, 11] and of fetal hyperinsulinism [13] . We postulate that, if fetal hyperinsulinism causes hypoxia, as it does in experimental animals [3] , the lack of correlation may be due to the fetal hyperinsulinism itself. Keywords: Diabetes mellitus in pregnancy, fetal macrosomia, gestational diabetes, hyperglycemia-hyperinsulinism theory, maximal tolerated dose of insulin. figure 1 ). Celä confirme Findication dinique, fondee sur la theorie hyperglycemie-hyperinsulinemie [12] qui estime que peut eviter la macrosomie foetale en equilibrant de facon stricte le metabolisme maternel. Dans cette serie Finsuline etait injectee ä la dose maximale toleree (MTD), attitude therapeutique qui assure un controle metabolique excellent chez les meres [14, 15, 16] . Chez les multipares, les poids de naissance des enfants lors de la derniere grossesse etaient extremement inferieurs aux poids de naissance des enfants lors des grossesses precedentes (sans insuline a MTD) (tableau II). Nos resultats ne confirment pas Fhypothese recente [18] que les diabetiques enceintes ayant un controle metabolique strict au cours de la grossesse donnent naissance en regie generate ä des enfants hypotrophiques. On a egalement injecte Finsuline ä MTD ä des meres avec un diabete gestationnel et la macrosomie foetale a etc evitee (tableau I, figure  1 ). Celä confirme l'opinion de ceux qui croient qu'un regime doit accompagner Finjection d'insuline pour corriger les anomalies metaboliques legeres de ces patientes. Comme on s'y attendait, en raison de l'insuffisance placentaire, les enfants des patientes presentant des complications vasculaires, y compris celles qui ont des calcifications des vaisseaux pelviens (classe E de White), ont eu un retard de croissance (tableau I, figure 1 ). Le risque de retard de croissance intra-uterin dans la classe E n'a pas etc remarque dans la litterature, car, habituellement, on ne tient pas compte de la pathologic des vaisseaux pelviens et les patientes ne sont pas differentiees des classes A -C. La possibilite de prevenir la macrosomie foetale par un controle strict du diabete maternel est mise en question, en raison du manque de correlation [9, 11, 13] entre la macrosomie foetale et le degre d'hyperglycemie maternelle et Fhyperinsulinisme foetal. Notre these: lorsque, Fhyperinsulinisme foetal entraine une hypoxie, comme cela se produit en experimentation animale [3] , le manque de correlation peut etre, lui-meme, secondaire ä Fhyperinsulinisme foetal.
Mots-cles:
Diabete gestationnel, diabete sucre au cours de la grossesse, dose maximale toleree d'insuline, macrosomie foetale, theorie hyperglycemie-hyperinsulinisme.
